Cell Based Tech Weekly – Meatable Gets Dr. Mark Kotter’s OPTi-OX

Categories Weekly Report

CEO of Twist Bioscience (TWST), Emily Leproust, Ph.D is scheduled to present at Evercore ISI HealthCONx Conference on Thursday, November 29, 2018. You can watch live at 8:45am ET, or if you miss it you can watch it within 90 days here:  cellbased.link/tst223b1

Need to Know: Twist Bioscience manufactures synthetic DNA and boasts an impressive, proprietary silicone platform designed to synthesize genes at exponentially greater speeds than the current industry standard. This advanced technology is what landed TWST a massive contract with Ginkgo Bioworks – supplying up to 1.3B base pairs of DNA over four years.

All that and more here if you’d like to read their HealthCONx Conference presentation or download below:


Advancements

Dr. Mark Kotter and The Cambridge Department of Clinical Neurosciences are partnering with Meatable to implement a new proprietary technique to convert pluripotent cells into bovine muscle and fat cells called OPTI-OX.

Before this conversion happens, Meatable extracts umbilical cord stem cells from a calf after birth and subsequently transcribes these cells into pluripotent stem cells. Dr. Kotter and Meatable believe that OPTI-OX will convert pluripotent cells into bovine muscle and fat cells significantly faster and with a high level of accuracy. https://www.varsity.co.uk/science/16612


Publicity

What do the top U.S. based cell based food startups have in common? Clara Foods, Geltor, Finless Foods, Memphis Meats, New Wave Foods, New Age Meats are all backed by the Biotech incubator, IndieBio — the company establishing Silicon Valley as the leading biology hub in the world. http://cellbased.link/bloom80a34

Rethink Events is hosting Agri-Food Innovation Week in Singapore. Thursday’s agenda, will feature a segment on cell-based meat opportunities in Southeast Asia. Here’s the speaker lineup:


Regulation

The Italian Agricultural Association, Coldiretti, has expressed disdain towards cell based meat on the basis that 75% of Italians have a negative view of the product. The total data set was not provided. http://cellbased.link/b8e8d